title: Resolvin D series and protectin D1 mitigate acute kidney injury.
abstract: Omega-3 fatty acid docosahexaenoic acid is converted to potent resolvins (Rv) and protectin D1 (PD1), two newly identified families of natural mediators of resolution of inflammation. We report that, in response to bilateral ischemia/reperfusion injury, mouse kidneys produce D series resolvins (RvDs) and PD1. Administration of RvDs or PD1 to mice before the ischemia resulted in a reduction in functional and morphological kidney injury. Initiation of RvDs and RvD1 administration 10 min after reperfusion also resulted in protection of the kidney as measured by serum creatinine 24 and 48 h later. Interstitial fibrosis after ischemia/reperfusion was reduced in mice treated with RvDs. Both RvDs and PD1 reduced the number of infiltrating leukocytes and blocked TLR-mediated activation of macrophages. Thus, the renal production of Rv and protectins, a previously unrecognized endogenous anti-inflammatory response, may play an important role in protection against and resolution of acute kidney injury. These data may also have therapeutic implications for potentiation of recovery from acute kidney injury.
authors.affiliation: Renal Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. jduffield@rics.bwh.harvard.edu
authors.forename: Jeremy S
authors.initials: JS
authors.lastname: Duffield
authors.forename: Song
authors.initials: S
authors.lastname: Hong
authors.forename: Vishal S
authors.initials: VS
authors.lastname: Vaidya
authors.forename: Yan
authors.initials: Y
authors.lastname: Lu
authors.forename: Gabrielle
authors.initials: G
authors.lastname: Fredman
authors.forename: Charles N
authors.initials: CN
authors.lastname: Serhan
authors.forename: Joseph V
authors.initials: JV
authors.lastname: Bonventre
mesh_terms: D000208:Acute Disease; D000818:Animals; D004281:Docosahexaenoic Acids / Q000378:metabolism* / Q000627:therapeutic use*; D015525:Fatty Acids, Omega-3 / Q000378:metabolism* / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D007962:Leukocytes / Q000187:drug effects / Q000276:immunology; D008297:Male; D051379:Mice; D015427:Reperfusion Injury / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*
chemical_list: D015525:Fatty Acids, Omega-3; C487679:protectin D1; D004281:Docosahexaenoic Acids